Cancer Drug Developer Dr. Steve Potts' Congressional Testimony on the IRA

episode

Vital Health Podcast not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

Richard Arnold: US Correspondent talks potential escalation from US in the Middle East 5 min · 20 Sep 2026 · The Mike Hosking Breakfast

Chris Luxon: Prime Minister talks National's supermarket policy, police targets and the public sector 12 min · 20 Sep 2026 · The Mike Hosking Breakfast

NPR News: 09-20-2026 4PM EDT 4 min · 20 Sep 2026 · NPR News Now

World Championships Time Trial 2026 30 min · 20 Sep 2026 · Lanterne Rouge Cycling Podcast

4PM ET 09/20/2026 Newscast 3 min · 20 Sep 2026 · Fox News Hourly Update

Luke Cook, being. with Lael Stone | Rather Cringe Than Bland ♥︎ 55 min · 20 Sep 2026 · Humans, being. with Lael Stone

Report any issue

Source

Recorded27 Sep 2023

Publisheromnycontent.com ↗

Handlerec:12782775

Show notes

In this Vital Health Podcast, we’re speaking with Steve Potts before his congressional testimony for the U.S. House Committee on Energy and Commerce. Steve presented evidence regarding the negative impacts of the Inflation Reduction Act on U.S. venture capital investors, the development of small molecules, and the needed therapies that will most likely be lost to patients over the next ten years. Steve is a hugely successful serial entrepreneur in the life sciences, leading several companies to develop new cancer treatments. He is a board member of AZBio and an expert on the development of small molecules for the treatment of cancer. See omnystudio.com/listener for privacy information.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in